FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 143 filers reported holding FLEXION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 3.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $358,000 | -34.4% | 58,674 | -11.6% | 0.00% | -100.0% |
Q2 2021 | $546,000 | -7.6% | 66,400 | +0.6% | 0.00% | 0.0% |
Q1 2021 | $591,000 | -22.7% | 66,013 | -0.4% | 0.00% | 0.0% |
Q4 2020 | $765,000 | +10.9% | 66,251 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $690,000 | +0.6% | 66,251 | +26.9% | 0.00% | 0.0% |
Q2 2020 | $686,000 | +66.9% | 52,191 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $411,000 | -61.5% | 52,191 | +1.2% | 0.00% | -50.0% |
Q4 2019 | $1,068,000 | +48.1% | 51,590 | -2.0% | 0.00% | +100.0% |
Q3 2019 | $721,000 | +12.7% | 52,632 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $640,000 | -0.3% | 52,004 | +1.1% | 0.00% | 0.0% |
Q1 2019 | $642,000 | +7.7% | 51,427 | -2.2% | 0.00% | 0.0% |
Q4 2018 | $596,000 | -38.0% | 52,607 | +2.3% | 0.00% | -50.0% |
Q3 2018 | $962,000 | -27.6% | 51,400 | -0.0% | 0.00% | -33.3% |
Q2 2018 | $1,329,000 | +19.1% | 51,403 | +3.2% | 0.00% | +50.0% |
Q1 2018 | $1,116,000 | -13.8% | 49,811 | -3.6% | 0.00% | -33.3% |
Q4 2017 | $1,294,000 | +20.6% | 51,660 | +16.4% | 0.00% | +50.0% |
Q3 2017 | $1,073,000 | +8.1% | 44,366 | -9.7% | 0.00% | 0.0% |
Q2 2017 | $993,000 | -29.9% | 49,113 | -6.7% | 0.00% | -33.3% |
Q1 2017 | $1,416,000 | +35.1% | 52,613 | -4.5% | 0.00% | +50.0% |
Q4 2016 | $1,048,000 | +9.2% | 55,113 | +12.2% | 0.00% | 0.0% |
Q3 2016 | $960,000 | +65.2% | 49,113 | +26.5% | 0.00% | +100.0% |
Q2 2016 | $581,000 | +111.3% | 38,813 | +30.0% | 0.00% | 0.0% |
Q1 2016 | $275,000 | -44.7% | 29,856 | +15.7% | 0.00% | 0.0% |
Q4 2015 | $497,000 | +32.2% | 25,798 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $376,000 | -32.4% | 25,307 | -0.4% | 0.00% | 0.0% |
Q2 2015 | $556,000 | +120.6% | 25,407 | +127.2% | 0.00% | 0.0% |
Q1 2015 | $252,000 | +11.5% | 11,184 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $226,000 | +48.7% | 11,184 | +34.0% | 0.00% | – |
Q3 2014 | $152,000 | +36.9% | 8,348 | +1.8% | 0.00% | – |
Q2 2014 | $111,000 | -17.8% | 8,200 | 0.0% | 0.00% | – |
Q1 2014 | $135,000 | – | 8,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |